COMMUNIQUÉS West-GlobeNewswire

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
04/07/2026
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases [...]
Transactions of Managers and Closely Associated Persons
03/07/2026
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 [...]
Burntide Gummies 2026 Update Highlights Ingredient Panel, Supplement Facts and Customer Service Support Details
03/07/2026
Apple Cider Vinegar, BHB Salts, and the Supplement Facts Panel Behind Burntide Gummies' Manufacturing Standards, Explained Largo, FL, July 03, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
HorseBoost Gummies Officially Debut Featuring the Trendy Horse Gelatin Salt Trick Recipe for Male Enhancement
03/07/2026
Muira Puama, Maca, Ashwagandha, and L-Arginine Combine in a Male Vitality Gummy Formula Explained for Adult Men Largo, FL, July 03, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2026
03/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 juin au 26 juin 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 26- 2026
03/07/2026
Aggregated presentation by day and by market Purchases of own shares from June 22nd to June 26th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
Delta Clinics Reports Increase in Demand for Body Contouring Treatments
03/07/2026
Delta Clinics notes evolving patient preferences toward comprehensive body contouring procedures, often combining multiple treatments for more balanced results. The clinic attributes this shift to changing aesthetic [...]
HEALBE's Technology Powers SHARP's First Health-Focused Smartwatch
03/07/2026
SHARP Corporation integrates HEALBE's patented FLOW® technology into the Karada Mate Watch, enabling automatic calorie intake and hydration estimation Redwood City, CA, July 03, 2026 (GLOBE NEWSWIRE) -- SHARP [...]
COSCIENS Biopharma Inc. Completes Share Capital Amendment
03/07/2026
TORONTO, ONTARIO, July 03, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”), today announced the previously announced consolidation (the “ Consolidation ”) of [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2026
SAN DIEGO, July 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
03/07/2026
ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 Orion will publish Half-Year Report for January–June 2026 on Friday, 17 [...]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2026
MONTREAL and CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
WILMINGTON, Del., July 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an [...]
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
02/07/2026
NEW YORK and WALTHAM, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
NAARDEN, The Netherlands and MIAMI, July 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
02/07/2026
IRVINE, California – July 2, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
02/07/2026
Longtime Clinical Advisor and Capsule Endoscopy Pioneer Joins Board as Company Advances AI-Enabled Capsule Endoscopy Platform SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a [...]
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of [...]

Pages